Results 151 to 160 of about 4,709 (168)

Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial

Lancet, The, 2018
Ajay K Gupta, Andrew J O Whitehouse, Thomas Godec   +2 more
exaly  

Estimating an exchange rate between the EQ-5D-3L and ASCOT

European Journal of Health Economics, 2017
Katherine Stevens, John Brazier, Donna Rowen   +2 more
exaly  

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Lancet, The, 2005
Neil R Poulter, D Gareth Beevers, Mark J Caulfield   +2 more
exaly  

Grammatical Tagging in ASCOT

1987
Eric Akkerman, Willem Meijs, Hetty Voogt van Zutphen   +2 more
openaire   +1 more source

Ascot pine woods

Notes and Queries, 1886
openaire   +1 more source

Results from the ASCOT Trial

MD Conference Express, 2010
M. Vinall, P. S. Sever
openaire   +1 more source

The Design of the ASCOT—Codes

1985
Erik Akkerman, Pieter Masereeuw, Willem Meijs   +2 more
openaire   +1 more source

Quality of life in a broader perspective: Does ASCOT reflect the capability approach?

Quality of Life Research, 2017
M S Van Loon, J E Bosmans, Guy Widdershoven   +2 more
exaly  

The Conduit Artery Functional Endpoint (CAFE) study in ASCOT

Journal of Human Hypertension, 2002
M O'Rourke, Williams B
exaly  

alternative uses for ascot

2017
openaire   +1 more source